The European pen needle market is anticipated to grow at a CAGR of 7.7% during the forecast period. The lucrative growth of the region is attributed to the presence of key players such as B. Braun Melsungen AG, Novo Nordisk A/S, Smiths Group Plc., and Vygon SA, which are pioneers in innovation, design, and manufacture of pen needles. Additionally, easy availability of pen needle across the region also aid to the growing shares of the market.
Furthermore, a rise in cases of needlestick injuries in the region is another major factor that fuels the demand for pen needles. For instance, according to the European Parliament, more than one million needlestick injuries are reported every year in Europe. Moreover, the surge in awareness related to the damage caused by needlestick injuries propels the growth of this market.
To Request a Sample of our Report on European Pen Needle Market: https://www.omrglobal.com/request-sample/european-pen-needle-market
The European pen needle market is segmented based on type, therapy, and mode of purchase. Based on the type, the market is sub-segmented into a standard pen needle and safety pen needle. The standard pen needles segment is estimated to contribute a significant share in the market. Based on the therapy, the market is sub-segmented into, insulin, GLP-1, growth hormones. Pen needles for insulin are estimated to contribute a prominent share in the market and are projected to do so during the forecast period. Based on the mode of purchase, the market is bifurcated into retail and non-retail. The retail segment is estimated to contribute significantly to market growth.
(Get 15% Discount on Buying this Report)
A full Report of European Pen Needle Market is Available at: https://www.omrglobal.com/industry-reports/european-pen-needle-market
European Pen Needle Market Segmentation
By Type
- Standard Pen Needles
- Safety Pen Needles
By Therapy
- Insulin
- GLP-1
- Growth Hormones
By Mode of Purchase
- Retail
- Non-Retail
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
